Radiofrequency ablation of unresectable hepatic tumors
To evaluate the efficacy and safety of radiofrequency ablation (RFA) in the treatment of primary and metastatic liver malignancies. Twenty-nine consecutive patients who have primary (n=9) and metastatic (n=20) liver malignancies were treated with RFA. The total number of lesions were 62 at the initi...
Gespeichert in:
| Veröffentlicht in: | Diagnostic and interventional radiology (Ankara, Turkey) Turkey), 2006-12, Vol.12 (4), p.195-200 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 200 |
|---|---|
| container_issue | 4 |
| container_start_page | 195 |
| container_title | Diagnostic and interventional radiology (Ankara, Turkey) |
| container_volume | 12 |
| creator | Geyik, Serdar Akhan, Okan Abbasoğlu, Osman Akinci, Devrim Ozkan, Orhan Seref Hamaloğlu, Erhan Ozmen, Mustafa |
| description | To evaluate the efficacy and safety of radiofrequency ablation (RFA) in the treatment of primary and metastatic liver malignancies.
Twenty-nine consecutive patients who have primary (n=9) and metastatic (n=20) liver malignancies were treated with RFA. The total number of lesions were 62 at the initiation of treatment and 28 new lesions were diagnosed at the follow-up period. Totally, 84 lesions were ablated with RFA technique at 46 sessions. Primary tumors that gave rise to metastatic lesion were all colorectal cancer except one with gallbladder carcinoma. The greatest tumor diameter immediately before treatment was 0.8-5 cm with a mean of 2.5 cm.
In the hepatocellular carcinoma (HCC) group, 1 patient was lost to follow-up, 5 deceased due to extensive disease, and 3 are still on the follow-up. In the metastatic liver disease group, 8 patients died due to progression of disease, 1 deceased due to stroke, and 3 were lost to follow-up. Nine patients with HCC had 14 nodules with a mean of 1.75 lesions/patient and 20 patients had 70 metastatic lesion with a mean of 3.1 lesions/patient. Residual viable neoplastic tissue was found at control computed tomography in 1 (1/14) lesion and recurrence occurred in 3 (3/14) lesions in HCC group. Recurrence occurred in 7 lesions (7/70) of 4 patients (4/20) in the metastatic liver disease group. Drainage requiring empyema took place in 1 patient and skin burn was observed in 2 as complications due to procedure.
RFA of primary and metastatic liver malignancies is a safe and effective tool for local control of disease in unresectable hepatic malignancies. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_68231117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3668241671</sourcerecordid><originalsourceid>FETCH-LOGICAL-p152t-2fcb231154cafefa373c7d8a21cbab3047dc3513605259d306f533619f4d1bcc3</originalsourceid><addsrcrecordid>eNpdkE1LxDAQhoMo7rr6F6QgeCtkMk3aHmXxCxYE0XPJJ3Zpm5o0h_33Rty9eJph3oeXhzkja0DKSxTAzk97w_iKXMW4p5TzFqpLsoIaBG0oXxPxLk3vXbDfyU76UEg1yKX3U-FdkaZgo9VLvtniy8450MWSRh_iNblwcoj25jg35PPp8WP7Uu7enl-3D7tyBs6WkjmtGALwSktnncQadW0ayUArqZBWtdHIAQXljLcGqXAcs3zrKgNKa9yQ-7_eOfhsGJdu7KO2wyAn61PsRPNbD3UG7_6Be5_ClN06ELVA5A1rM3V7pJIarenm0I8yHLrTP_AHO2Jb9w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1676335829</pqid></control><display><type>article</type><title>Radiofrequency ablation of unresectable hepatic tumors</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Geyik, Serdar ; Akhan, Okan ; Abbasoğlu, Osman ; Akinci, Devrim ; Ozkan, Orhan Seref ; Hamaloğlu, Erhan ; Ozmen, Mustafa</creator><creatorcontrib>Geyik, Serdar ; Akhan, Okan ; Abbasoğlu, Osman ; Akinci, Devrim ; Ozkan, Orhan Seref ; Hamaloğlu, Erhan ; Ozmen, Mustafa</creatorcontrib><description>To evaluate the efficacy and safety of radiofrequency ablation (RFA) in the treatment of primary and metastatic liver malignancies.
Twenty-nine consecutive patients who have primary (n=9) and metastatic (n=20) liver malignancies were treated with RFA. The total number of lesions were 62 at the initiation of treatment and 28 new lesions were diagnosed at the follow-up period. Totally, 84 lesions were ablated with RFA technique at 46 sessions. Primary tumors that gave rise to metastatic lesion were all colorectal cancer except one with gallbladder carcinoma. The greatest tumor diameter immediately before treatment was 0.8-5 cm with a mean of 2.5 cm.
In the hepatocellular carcinoma (HCC) group, 1 patient was lost to follow-up, 5 deceased due to extensive disease, and 3 are still on the follow-up. In the metastatic liver disease group, 8 patients died due to progression of disease, 1 deceased due to stroke, and 3 were lost to follow-up. Nine patients with HCC had 14 nodules with a mean of 1.75 lesions/patient and 20 patients had 70 metastatic lesion with a mean of 3.1 lesions/patient. Residual viable neoplastic tissue was found at control computed tomography in 1 (1/14) lesion and recurrence occurred in 3 (3/14) lesions in HCC group. Recurrence occurred in 7 lesions (7/70) of 4 patients (4/20) in the metastatic liver disease group. Drainage requiring empyema took place in 1 patient and skin burn was observed in 2 as complications due to procedure.
RFA of primary and metastatic liver malignancies is a safe and effective tool for local control of disease in unresectable hepatic malignancies.</description><identifier>ISSN: 1305-3825</identifier><identifier>EISSN: 1305-3612</identifier><identifier>PMID: 17160805</identifier><language>eng</language><publisher>Turkey: Aves Yayincilik Ltd. STI</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular - diagnostic imaging ; Carcinoma, Hepatocellular - epidemiology ; Carcinoma, Hepatocellular - etiology ; Carcinoma, Hepatocellular - pathology ; Catheter Ablation - adverse effects ; Catheter Ablation - utilization ; Female ; Humans ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - epidemiology ; Liver Neoplasms - pathology ; Liver Neoplasms - therapy ; Male ; Middle Aged ; Neoplasm Recurrence, Local - diagnostic imaging ; Neoplasm Recurrence, Local - epidemiology ; Neoplasm Recurrence, Local - etiology ; Neoplasm Recurrence, Local - pathology ; Outcome Assessment (Health Care) ; Postoperative Complications ; Retrospective Studies ; Severity of Illness Index ; Tomography, X-Ray Computed ; Turkey - epidemiology</subject><ispartof>Diagnostic and interventional radiology (Ankara, Turkey), 2006-12, Vol.12 (4), p.195-200</ispartof><rights>Copyright Aves Yayincilik Ltd. STI. Dec 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17160805$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Geyik, Serdar</creatorcontrib><creatorcontrib>Akhan, Okan</creatorcontrib><creatorcontrib>Abbasoğlu, Osman</creatorcontrib><creatorcontrib>Akinci, Devrim</creatorcontrib><creatorcontrib>Ozkan, Orhan Seref</creatorcontrib><creatorcontrib>Hamaloğlu, Erhan</creatorcontrib><creatorcontrib>Ozmen, Mustafa</creatorcontrib><title>Radiofrequency ablation of unresectable hepatic tumors</title><title>Diagnostic and interventional radiology (Ankara, Turkey)</title><addtitle>Diagn Interv Radiol</addtitle><description>To evaluate the efficacy and safety of radiofrequency ablation (RFA) in the treatment of primary and metastatic liver malignancies.
Twenty-nine consecutive patients who have primary (n=9) and metastatic (n=20) liver malignancies were treated with RFA. The total number of lesions were 62 at the initiation of treatment and 28 new lesions were diagnosed at the follow-up period. Totally, 84 lesions were ablated with RFA technique at 46 sessions. Primary tumors that gave rise to metastatic lesion were all colorectal cancer except one with gallbladder carcinoma. The greatest tumor diameter immediately before treatment was 0.8-5 cm with a mean of 2.5 cm.
In the hepatocellular carcinoma (HCC) group, 1 patient was lost to follow-up, 5 deceased due to extensive disease, and 3 are still on the follow-up. In the metastatic liver disease group, 8 patients died due to progression of disease, 1 deceased due to stroke, and 3 were lost to follow-up. Nine patients with HCC had 14 nodules with a mean of 1.75 lesions/patient and 20 patients had 70 metastatic lesion with a mean of 3.1 lesions/patient. Residual viable neoplastic tissue was found at control computed tomography in 1 (1/14) lesion and recurrence occurred in 3 (3/14) lesions in HCC group. Recurrence occurred in 7 lesions (7/70) of 4 patients (4/20) in the metastatic liver disease group. Drainage requiring empyema took place in 1 patient and skin burn was observed in 2 as complications due to procedure.
RFA of primary and metastatic liver malignancies is a safe and effective tool for local control of disease in unresectable hepatic malignancies.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma, Hepatocellular - diagnostic imaging</subject><subject>Carcinoma, Hepatocellular - epidemiology</subject><subject>Carcinoma, Hepatocellular - etiology</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Catheter Ablation - adverse effects</subject><subject>Catheter Ablation - utilization</subject><subject>Female</subject><subject>Humans</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - epidemiology</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - diagnostic imaging</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neoplasm Recurrence, Local - etiology</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Outcome Assessment (Health Care)</subject><subject>Postoperative Complications</subject><subject>Retrospective Studies</subject><subject>Severity of Illness Index</subject><subject>Tomography, X-Ray Computed</subject><subject>Turkey - epidemiology</subject><issn>1305-3825</issn><issn>1305-3612</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkE1LxDAQhoMo7rr6F6QgeCtkMk3aHmXxCxYE0XPJJ3Zpm5o0h_33Rty9eJph3oeXhzkja0DKSxTAzk97w_iKXMW4p5TzFqpLsoIaBG0oXxPxLk3vXbDfyU76UEg1yKX3U-FdkaZgo9VLvtniy8450MWSRh_iNblwcoj25jg35PPp8WP7Uu7enl-3D7tyBs6WkjmtGALwSktnncQadW0ayUArqZBWtdHIAQXljLcGqXAcs3zrKgNKa9yQ-7_eOfhsGJdu7KO2wyAn61PsRPNbD3UG7_6Be5_ClN06ELVA5A1rM3V7pJIarenm0I8yHLrTP_AHO2Jb9w</recordid><startdate>200612</startdate><enddate>200612</enddate><creator>Geyik, Serdar</creator><creator>Akhan, Okan</creator><creator>Abbasoğlu, Osman</creator><creator>Akinci, Devrim</creator><creator>Ozkan, Orhan Seref</creator><creator>Hamaloğlu, Erhan</creator><creator>Ozmen, Mustafa</creator><general>Aves Yayincilik Ltd. STI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200612</creationdate><title>Radiofrequency ablation of unresectable hepatic tumors</title><author>Geyik, Serdar ; Akhan, Okan ; Abbasoğlu, Osman ; Akinci, Devrim ; Ozkan, Orhan Seref ; Hamaloğlu, Erhan ; Ozmen, Mustafa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p152t-2fcb231154cafefa373c7d8a21cbab3047dc3513605259d306f533619f4d1bcc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma, Hepatocellular - diagnostic imaging</topic><topic>Carcinoma, Hepatocellular - epidemiology</topic><topic>Carcinoma, Hepatocellular - etiology</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Catheter Ablation - adverse effects</topic><topic>Catheter Ablation - utilization</topic><topic>Female</topic><topic>Humans</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - epidemiology</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - diagnostic imaging</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neoplasm Recurrence, Local - etiology</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Outcome Assessment (Health Care)</topic><topic>Postoperative Complications</topic><topic>Retrospective Studies</topic><topic>Severity of Illness Index</topic><topic>Tomography, X-Ray Computed</topic><topic>Turkey - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Geyik, Serdar</creatorcontrib><creatorcontrib>Akhan, Okan</creatorcontrib><creatorcontrib>Abbasoğlu, Osman</creatorcontrib><creatorcontrib>Akinci, Devrim</creatorcontrib><creatorcontrib>Ozkan, Orhan Seref</creatorcontrib><creatorcontrib>Hamaloğlu, Erhan</creatorcontrib><creatorcontrib>Ozmen, Mustafa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic and interventional radiology (Ankara, Turkey)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Geyik, Serdar</au><au>Akhan, Okan</au><au>Abbasoğlu, Osman</au><au>Akinci, Devrim</au><au>Ozkan, Orhan Seref</au><au>Hamaloğlu, Erhan</au><au>Ozmen, Mustafa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radiofrequency ablation of unresectable hepatic tumors</atitle><jtitle>Diagnostic and interventional radiology (Ankara, Turkey)</jtitle><addtitle>Diagn Interv Radiol</addtitle><date>2006-12</date><risdate>2006</risdate><volume>12</volume><issue>4</issue><spage>195</spage><epage>200</epage><pages>195-200</pages><issn>1305-3825</issn><eissn>1305-3612</eissn><abstract>To evaluate the efficacy and safety of radiofrequency ablation (RFA) in the treatment of primary and metastatic liver malignancies.
Twenty-nine consecutive patients who have primary (n=9) and metastatic (n=20) liver malignancies were treated with RFA. The total number of lesions were 62 at the initiation of treatment and 28 new lesions were diagnosed at the follow-up period. Totally, 84 lesions were ablated with RFA technique at 46 sessions. Primary tumors that gave rise to metastatic lesion were all colorectal cancer except one with gallbladder carcinoma. The greatest tumor diameter immediately before treatment was 0.8-5 cm with a mean of 2.5 cm.
In the hepatocellular carcinoma (HCC) group, 1 patient was lost to follow-up, 5 deceased due to extensive disease, and 3 are still on the follow-up. In the metastatic liver disease group, 8 patients died due to progression of disease, 1 deceased due to stroke, and 3 were lost to follow-up. Nine patients with HCC had 14 nodules with a mean of 1.75 lesions/patient and 20 patients had 70 metastatic lesion with a mean of 3.1 lesions/patient. Residual viable neoplastic tissue was found at control computed tomography in 1 (1/14) lesion and recurrence occurred in 3 (3/14) lesions in HCC group. Recurrence occurred in 7 lesions (7/70) of 4 patients (4/20) in the metastatic liver disease group. Drainage requiring empyema took place in 1 patient and skin burn was observed in 2 as complications due to procedure.
RFA of primary and metastatic liver malignancies is a safe and effective tool for local control of disease in unresectable hepatic malignancies.</abstract><cop>Turkey</cop><pub>Aves Yayincilik Ltd. STI</pub><pmid>17160805</pmid><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1305-3825 |
| ispartof | Diagnostic and interventional radiology (Ankara, Turkey), 2006-12, Vol.12 (4), p.195-200 |
| issn | 1305-3825 1305-3612 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68231117 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adolescent Adult Aged Aged, 80 and over Carcinoma, Hepatocellular - diagnostic imaging Carcinoma, Hepatocellular - epidemiology Carcinoma, Hepatocellular - etiology Carcinoma, Hepatocellular - pathology Catheter Ablation - adverse effects Catheter Ablation - utilization Female Humans Liver Neoplasms - diagnostic imaging Liver Neoplasms - epidemiology Liver Neoplasms - pathology Liver Neoplasms - therapy Male Middle Aged Neoplasm Recurrence, Local - diagnostic imaging Neoplasm Recurrence, Local - epidemiology Neoplasm Recurrence, Local - etiology Neoplasm Recurrence, Local - pathology Outcome Assessment (Health Care) Postoperative Complications Retrospective Studies Severity of Illness Index Tomography, X-Ray Computed Turkey - epidemiology |
| title | Radiofrequency ablation of unresectable hepatic tumors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T12%3A18%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radiofrequency%20ablation%20of%20unresectable%20hepatic%20tumors&rft.jtitle=Diagnostic%20and%20interventional%20radiology%20(Ankara,%20Turkey)&rft.au=Geyik,%20Serdar&rft.date=2006-12&rft.volume=12&rft.issue=4&rft.spage=195&rft.epage=200&rft.pages=195-200&rft.issn=1305-3825&rft.eissn=1305-3612&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E3668241671%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1676335829&rft_id=info:pmid/17160805&rfr_iscdi=true |